Nadine joined Brandon Capital in 2021.
Dr Nadine Brew (B.A/B.Sc(Hons), PhD, GAICD) is a Portfolio Manager at Brandon Capital, delivering operations and corporate services to its life science portfolio companies. She has strong experience in biotechnology operations and management spanning senior roles in industry, health charity, hospital and university settings. She has led a range of commercial deals, industry engagement and partnering programs to progress the pre-clinical and clinical development of academic research.
Dr Brew has over a decade’s laboratory research experience in Australia and the US with a PhD in developmental physiology from Monash University, during which she was the recipient of an NH&MRC postgraduate scholarship. In her postdoctoral studies investigating neurodevelopment and brain injury in preterm infants she received a Churchill Fellowship and spent time at Children’s National Hospital in Washington DC.
Dr Brew’s research commercialisation experience includes roles as Business Development Manger at Hudson Institute of Medical Research and with Monash Innovation. She is co-founder of an executive STEM women’s leadership program, the WILD Program, is a graduate of the Australian Institute of Company Directors and has been an observer on numerous boards.
